First AD

Second AD

Breast Cancer

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Supportive Care

The OncLive Supportive Care condition center page is a comprehensive resource for clinical news and expert insights on supportive care and management of patients with cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, best practices, and ongoing research as it relates to supportive care for patients with cancer.

Oncology Nursing News

The OncLive Nursing News condition center page is a comprehensive resource for clinical news and expert insights for oncology nurses and their best practices for treating patients with cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research across malignancies that can be beneficial for oncology nurses.

HER2+ Breast Cancer

The OncLive Neoadjuvant HER2+ Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with HER2-positive breast cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research in HER2-positive breast cancer.

Expanding Treatment Options for Metastatic Breast Cancer

Peer Exchange

Compliance and Adherence to Therapy in mBC

Treatment After Progression on CDK 4/6i in mBC

SOLAR-1 Trial in Metastatic Breast Cancer

Payer Perspective of Coverage on Cancer Therapies

Payer Coverage on Repeat Biopsy in mBC

Advantages of Oral Taxanes in mBC

Payer Coverage of IV Versus Oral Therapy in mBC

Evolving Treatment Landscape of R/R HER2+ mBC

HER2CLIMB and NALA Trials: R/R HER2+ mBC

SOPHIA Trial in R/R HER2+ mBC

Sequencing of Therapy in R/R HER2+ mBC

IMpassion130 Trial Data on PD-L1+ Tumors in TNBC

Role of PARP Inhibition and I/O Therapy in TNBC

Treatment Options in Metastatic TNBC

Considerations for NGS Testing in mTNBC

Assessing the Value of Personalized Treatment in mBC

Closing Thoughts on Metastatic Breast Cancers